1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
674356295666B950565257C1B0040308B
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/competitive-intelligence-sources-activities-deliverables?opendocument
18
19opendocument
2034.229.194.198
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Competitive and Business Intelligence Strategic Insights

Competitive Intelligence Excellence: Key CI Sources, Activities and Deliverables

ID: 5275


Features:

11 Info Graphics

13 Data Graphics

150+ Metrics


Pages/Slides: 31


Published: 2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Competitive Intelligence Excellence: Key CI Sources, Activities and Deliverables."

STUDY OVERVIEW

Effective Competitive Intelligence (CI) groups help guide the strategic direction of organizations facing a rapidly changing market place. In short, effective CI enables companies to make better decisions - and avoid corporate risk. Key operational components of a CI group include the sources it uses to gather information, the activities it conducts to gather/analyze information and the deliverables it creates to inform the organization.


Best Practices, LLC conducted this study to surface the CI sources, activities and deliverables that CI leaders are using to improve the strategic role and impact of the Competitive Intelligence function within pharmaceutical and related industries. The study provides health care industry and CI leaders with metrics and insights they can use to increase the value of their function and generate greater influence within the corporation.


KEY TOPICS

  • Sources & Activities
  • Key primary & secondary research activities
  • When to use primary sources
  • CI source effectiveness
  • CI from social media & internal employees
  • Most effective activities
  • Percentage of work that is analysis

KEY METRICS
  • Sources used for primary CI research
  • Sources used by companies for secondary CI research
  • Top 3 CI sources & tools used
  • Effectiveness of primary CI research sources
  • Effectiveness of secondary CI research sources
  • Effectiveness of Internet/ Online resources for CI
  • Innovative social media and other online resources for CI
  • Total percentage of primary vs. secondary CI research activities
  • Total percentage of CI deliverable types
  • Core CI activities followed by organizations
  • Effectiveness of capturing CI insights (conferences, trade shows or meetings)
  • Practices followed for collecting CI data from internal employees
  • Top 3 influencial CI activities


SAMPLE KEY FINDINGS

Competitive Intelligence Sources
  • Top 3 Sources and Tools:Participants cited a wide variety of CI sources and tools they must have to do their jobs effectively. These fell loosely into seven different categories including:
    • Pipeline databases
    • CI vendors
    • Industry experts/KOLs and other human contacts
    • Sales data
    • Investment reports
    • News services
    • Medical congresses
Competitive Intelligence Activities
  • Social Media:
    • Social media resources currently are little used (and often ineffective) for collecting CI.
    • Only 40% report any innovative uses of social media for CI.
    • You Tube, which rated better in the study than Facebook or Twitter, is used by only 42%, and, of those, more than one quarter found it not effective.

STUDY METHODOLGY

Thirty-five Competitive Intelligence leaders from 32 companies in the healthcare industry participated in this benchmarking study. Participants represented small, midcap and large biopharmaceutical and medical device companies. Seventy percent work in U.S. locations.

Industries Profiled:
Health Care; Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Distribution; Science; Technology


Companies Profiled:
Abbott Nutrition; Amgen; AstraZeneca; Ariad; Bayer; Biocon; Boehringer Ingelheim; B Braun; Covidien; Daiichi-Sankyo; Dentsply; EMD Serono; Emergent; Ethicon; Ferring; GSK; Glenmark; Janssen; Jazz; Johnson & Johnson; McKesson; Medtronic; Merck; Novo Nordisk; Pfizer; Purdue; Sanofi Pasteur; Teva; Torrent; Upsher-Smith; Waters; Wyeth Nutrition/Nestle


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.